donshafi911@IAmTheFaceOfTruth🔻

 

Pfizer’s Comirnaty mRNA COVID Vaccine Manufacturing Has Dropped by 89% Due to Decrease in Demand

July 28, 2023 • by David Shaw

The Follow the Money Team’s new report on Pfizer’s financials, based on Pfizer’s Q1 2023 reporting, offers many important insights:

• Pfizer reports that its mRNA COVID vaccine, Comirnaty^®, manufacturing activities, performed on behalf of BioNTech, dropped 89% to only $5 million quarter-over-quarter.
• In its Q1 2023 report, Pfizer assumes no growth in market share for COVID-19 vaccinations.
• Pfizer notes the Comirnaty’s decrease in uptake is due to “fewer primary vaccinations and non-compliance.”
• Pfizer’s Q1 2023 revenue was down 28.7%, and Earnings Per Share dropped 29% from Q1 2022.
• Pfizer’s 2023 revenue guidance is about $30 billion lower than 2022.
• The company’s stock price has dropped from a high of $59.48 on December 17, 2021, to a 52-week low of $36.51 on May 17, 2023, a 37% fall in just over 12 months.

Please read the full report below.

FTM Pfizer Financial Performance Micro Report #4

https://dailyclout.io/wp-content/uploads/FTM-Pfizer-Financial-Performance-Micro-Report-4-3.pdf

Order Your Copy of the Pfizer Reports Paperback Book.Please support DailyClout.Become a DailyClout Member.

TRANSLATE 

Manufaktur Vaksin COVID mRNA Comirnaty Pfizer Telah Turun 89% Karena Penurunan Permintaan
28 Juli 2023 • oleh David Shaw
Laporan baru Tim Follow the Money tentang keuangan Pfizer, berdasarkan laporan Q1 2023, menawarkan banyak wawasan penting:
Pfizer melaporkan bahwa vaksin mRNA COVID-nya, Comirnaty®, aktivitas manufaktur, dilakukan atas nama BioNTech, turun 89% menjadi hanya $5 juta kuartal-ke-kuartal.
Dalam laporan Q1 2023, Pfizer mengasumsikan tidak ada pertumbuhan dalam pangsa pasar untuk vaksinasi COVID-19.
Pfizer mencatat penurunan penyerapan Comirnaty disebabkan oleh "lebih sedikit vaksinasi primer dan ketidakpatuhan."
Pendapatan Pfizer Q1 2023 turun 28,7%, dan Laba Per Saham turun 29% dari Q1 2022.
Panduan pendapatan Pfizer tahun 2023 sekitar $30 miliar lebih rendah dari tahun 2022.
Harga saham perusahaan telah turun dari level tertinggi $59.48 pada 17 Desember 2021, ke level terendah 52 minggu di $36.51 pada 17 Mei 2023, penurunan 37% hanya dalam 12 bulan.
Silakan baca laporan lengkapnya di bawah ini.
Laporan Mikro Kinerja Keuangan FTM Pfizer #4
https://dailyclout.io/wp-content/uploads/FTM-Pfizer-Kinerja-Keuangan-Laporan-Mikro-4-3.pdf
Pesan Salinan Buku Sampul Tipis Laporan Pfizer Anda.
Tolong dukung DailyClout.
Menjadi Anggota DailyClout.